Mode of death after contemporary percutaneous coronary intervention: A report from the Evaluation of Drug Eluting Stents and Ischemic Events registry

American Heart Journal

Volumn 162, Issue 5, 2011, Pages 914-921

  Stolker, Joshua M ^a   Cohen, David J ^b   Lindsey, Jason B ^b   Kennedy, Kevin F ^b   Kleiman, Neal S ^c   Marso, Steven P ^b  

^a SAINT LOUIS UNIVERSITY   (United States)

^b Saint Luke's Mid America Heart and Vascular Institute   (United States)

^c HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CLINICAL PROTOCOL; DEATH; DIABETES MELLITUS; EXERCISE TEST; FEMALE; HEART LEFT VENTRICLE FAILURE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MODE OF DEATH; MORTALITY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REGISTER; SENSITIVITY ANALYSIS; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STABLE ANGINA PECTORIS; TIME OF DEATH; UNITED STATES;

AGED; ANGIOPLASTY, BALLOON, CORONARY; DRUG-ELUTING STENTS; FEMALE; HOSPITALS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; REGISTRIES; UNITED STATES;

EID: 81255124353     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2011.08.014     Document Type: Article

References (26)

1. S.B. King III A valuable public option JACC Cardiovasc Interv 3 2010 129 130
2. R.I. Levy, M.J. Jesse, and M.B. Mock NHLBI position on percutaneous transluminal coronary angioplasty Am J Cardiol 43 1979 867
3. S.B. King III, T. Aversano, and W.L. Ballard ACCF/AHA/SCAI 2007 update of the clinical competence statement on cardiac interventional procedures J Am Coll Cardiol 50 2007 82 108 (Pubitemid 46964924)
4. E.S. Ford, U.A. Ajani, and J.B. Croft Explaining the decrease in U.S. deaths from coronary disease, 1980-2000 N Engl J Med 356 2007 2388 2398 (Pubitemid 46883773)
5. D. Lloyd-Jones, R.J. Adams, and T.M. Brown Heart disease and stroke statistics-2010 update Circulation 121 2010 e46 e215
6. D.E. Cutlip, S. Windecker, and R. Mehran Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351 (Pubitemid 46685903)
7. S. Jacob, D.J. Cohen, and J. Massaro Design of a registry to characterize "real-world" outcomes of percutaneous coronary revascularization in the drug-eluting stent era Am Heart J 150 2005 887 892 (Pubitemid 41607758)
8. E.G. Bovill, R.P. Tracy, and G.L. Knatterud Hemorrhagic events during therapy with recombinant tissue plasminogen activator, heparin, and aspirin for unstable angina Am J Cardiol 79 1997 391 396 (Pubitemid 127440399)
9. F.G. Kushner, M. Hand, and S.C. Smith Jr. 2009 Focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction Circulation 120 2009 2271 2306
10. G.J. Laarman, M.J. Suttorp, and M.T. Dirksen Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention N Engl J Med 355 2006 1105 1113 (Pubitemid 44394917)
11. P.W. Serruys, M.C. Morice, and A.P. Kappetein Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease N Engl J Med 360 2009 961 972
12. C. Spaulding, P. Henry, and E. Teiger Sirolimus-eluting versus uncoated stents in acute myocardial infarction N Engl J Med 355 2006 1093 1104 (Pubitemid 44394916)
13. G.W. Stone, B. Witzenbichler, and G. Guagliumi Bivalirudin during primary PCI in acute myocardial infarction N Engl J Med 358 2008 2218 2230 (Pubitemid 351724451)
14. S. Windecker, P.W. Serruys, and S. Wandel Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS) Lancet 372 2008 1163 1173
15. S.G. Ellis, R.K. Myler, and S.B. King III Causes and correlates of death after unsupported coronary angioplasty: implications for use of angioplasty and advanced support techniques in high-risk settings Am J Cardiol 68 1991 1447 1451
16. E.L. Hannan, D.T. Arani, and L.W. Johnson Percutaneous transluminal coronary angioplasty in New York State. Risk factors and outcomes JAMA 268 1992 3092 3097
17. D.J. Malenka, D. O'Rourke, and M.A. Miller Cause of in-hospital death in 12,232 consecutive patients undergoing percutaneous transluminal coronary angioplasty Am Heart J 137 4 Pt 1 1999 632 638 (Pubitemid 29173574)
18. S. Rathore, M. Jackson, and R.A. Perry Circumstances and mode of in-hospital death in 5750 consecutive patients undergoing percutaneous transluminal coronary angioplasty Int J Cardiol 113 2006 139 140 (Pubitemid 44648353)
19. E.D. Peterson, D. Dai, and E.R. DeLong Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry J Am Coll Cardiol 55 2010 1923 1932
20. S. Rathore, A.D. Grayson, and S. Sastry Circumstances and mode of in-hospital death following 9,914 consecutive patients undergoing percutaneous coronary interventions in the northwest of England J Invasive Cardiol 20 2008 386 390
21. M. Busk, M. Maeng, and S.D. Kristensen Timing, causes, and predictors of death after three years' follow-up in the DANAMI-2 trial Am J Cardiol 104 2009 210 215
22. W.E. Boden, R.A. O'Rourke, and K.K. Teo Optimal medical therapy with or without PCI for stable coronary disease N Engl J Med 356 2007 1503 1516 (Pubitemid 46588415)
23. G.W. Stone, A.J. Lansky, and S.J. Pocock Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction N Engl J Med 360 2009 1946 1959
24. N. Sattar, D. Preiss, and H.M. Murray Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials Lancet 375 2011 735 742
25. D. Austin, K.G. Oldroyd, and D.R. Holmes Jr. Drug-eluting stents: a study of international practice Am Heart J 158 2009 576 584
26. R.J. Krone, S.V. Rao, and D. Dai Acceptance, panic, and partial recovery the pattern of usage of drug-eluting stents after introduction in the U.S JACC Cardiovasc Interv 3 2010 902 910